August 30, 2016 3:59 PM ET

Pharmaceuticals

Company Overview of Rapamycin Holdings, Inc.

Executive Profile

John W. Feik

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 6 different industries.

See Board Relationships
----

Background

Mr. John W. Feik served as President and Chief Operating Officer of DFB Pharmaceuticals, Inc. Mr. Feik was involved with many companies such as HealthPoint Biotherapeutics, Phyton Biotech, and StemBioSys, Inc. He has 35 years of experience in the pharmaceutical industry. He is philanthropist. He created Feik School of Pharmacy at the University of the Incarnate Word. He serves as a Director of StemBioSys, Inc. He has been a Director of ExThera Medical Corporation since ...

Corporate Headquarters

12500 Network Boulevard
San Antonio, Texas 78249

United States

Phone: 210-478-8678
Fax: --

Board Members Memberships

Trustee
Director
Director
2014-Present
Director

Education

Unknown/Other Education
The University of Texas System

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rapamycin Holdings, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.